2020-11-16,Nymox Provides Update on Regulatory Filing Activities
2020-11-03,What You Need To Know About Nymox Pharmaceutical Corporation's (NASDAQ:NYMX) Investor Composition
2020-08-12,Nymox Announces $9 Million Registered Direct Offering
2020-07-28,NYMOX Provides Current Update on Key Company Developments
2020-06-19,Nymox Announces Updates in Regulatory Submissions For Fexapotide Treatment For Prostate Enlargement
2020-06-05,Hedge Funds Cautiously Watching Pharmaceutical Corporation (NYMX)
2020-05-05,If You Had Bought Nymox Pharmaceutical (NASDAQ:NYMX) Shares Five Years Ago You'd Have Made 91%
2020-04-21,Nymox Announces Important New Patent Developments
2020-03-21,Is Nymox Pharmaceutical (NASDAQ:NYMX) In A Good Position To Deliver On Growth Plans?
2020-02-24,Nymox Announces New Peer Review Publication of Prostate Cancer Fexapotide Clinical Trial Results in World Journal of Urology
2020-02-06,Nymox Announces New Appointment of Russell Thomson Ph.D. as Nymox Vice President of Quality and Regulatory Affairs
2020-02-05,Is Nymox Pharmaceutical Corporation's (NASDAQ:NYMX) CEO Being Overpaid?
2020-01-28,Nymox Provides Update on Current Corporate Activities and Milestones
2020-01-07,"The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering"
2020-01-06,Nymox Announces New Peer Review Article on Fexapotide Pharmaco-Ablation Experimental Studies Published in Research and Reports in Urology
2019-12-23,Hedge Funds Have Never Been More Bullish On Nymox Pharmaceutical Corporation (NYMX)
2019-12-20,Nymox Pharmaceutical Corporation (NASDAQ:NYMX): What Does Its Beta Value Mean For Your Portfolio?
2019-11-05,The Nymox Pharmaceutical (NASDAQ:NYMX) Share Price Is Up 172% And Shareholders Are Boasting About It
2019-10-21,Nymox Reports on Newly Issued Patents and Corporate Developments
2019-07-24,Are Insiders Selling Nymox Pharmaceutical Corporation (NASDAQ:NYMX) Stock?
2019-07-08,6 Stocks to Buy Based on Insider Buying
2019-06-25,Nymox End of Q2 New Investor Presentation on Website
2019-06-18,What Kind Of Investor Owns Most Of Nymox Pharmaceutical Corporation (NASDAQ:NYMX)?
2019-05-15,Nymox: 1Q Earnings Snapshot
2019-05-10,"Before You Buy Nymox Pharmaceutical Corporation (NASDAQ:NYMX), Consider Its Volatility"
2019-04-16,Nymox Reports Pre-NDA CMC Meeting with the FDA
2019-03-21,"Nymox Teleconference Monday, March 25 10:00 a.m. EDT"
2019-03-19,"Nymox Announces Appointment of Mark Staples PhD as Vice President of Chemistry, Manufacturing and Controls (CMC)"
2019-03-18,"Introducing Nymox Pharmaceutical (NASDAQ:NYMX), The Stock That Slid 60% In The Last Five Years"
2019-03-13,Nymox Announces Appointment of Russell Thomson Ph.D. as Director of Quality and EU Qualified Person for Company's Manufacturing Operations
2019-03-11,Nymox to Host Investor Teleconference
2019-01-30,Does The Nymox Pharmaceutical Corporation (NASDAQ:NYMX) Share Price Fall With The Market?
2019-01-15,New Peer Review Article Entitled Efficacy and safety of fexapotide triflutate in outpatient medical treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia Published in Therapeutic Advances in Urology
2018-12-19,2018: A Year of Achievements for NYMOX
2018-12-14,Are Insiders Selling Nymox Pharmaceutical Corporation (NASDAQ:NYMX) Stock?
2018-11-13,Nymox: 3Q Earnings Snapshot
2018-10-11,Corporate Update To Shareholders: Preparatory Work For Regulatory Filings On Track
2018-10-09,Nymox Reports 78 Month Results From Biopsy and Surgery Confirmed Prospective Randomized NX03-0040 Prostate Cancer Study of Fexapotide Triflutate: Gleason Grade Progression Reduced by 81% Overall and Fexapotide 15mg Minimal Treatment Leads to 73% Long-Term Reduction in Incidence of Associated Prostate Cancer Surgery and Radiotherapy
2018-10-03,Nymox Reports Safety Benefits of Fexapotide Treatments for Prostate Cancer and Benign Prostatic Hyperplasia
2018-08-13,Nymox: 2Q Earnings Snapshot
2018-07-02,NYMOX Announces Expanded Marketing Plans
2018-06-07,NYMOX Successfully Achieves Manufacturing Scale-Up
2018-05-22,Fexapotide Triflutate Pivotal Phase 3 Study Results Presented and Discussed at American Urological Association Annual Meeting in San Francisco
2018-05-16,Nymox: 1Q Earnings Snapshot
2018-05-11,Nymoxs Fexapotide Featured in Broadcast of Grand Rounds in Urology
2018-05-07,Nymox Announces Relocation of Company Headquarters to Switzerland
2018-05-02,Nymox Announces Fexapotide Drug Symposium at AUA Annual Meeting San Francisco May 20
2018-05-01,What You Must Know About Nymox Pharmaceutical Corporations (NASDAQ:NYMX) Major Investors
2018-04-13,Should You Worry About Nymox Pharmaceutical Corporations (NASDAQ:NYMX) CEO Pay?
2018-04-12,Nymox Announces $16.25 Million Equity Financing With Qualified Long-Term Investors
2018-04-10,New Online Commentary in UroToday on Fexapotide BPH Clinical Trial Results Publication in World Journal of Urology
2018-03-19,Should You Have Nymox Pharmaceutical Corporations (NASDAQ:NYMX) In Your Portfolio?
2018-03-01,Symposium and Panel Discussion on Nymox's Fexapotide To Be Held at American Urological Association Mid-Atlantic Section Annual Meeting on March 3
2018-02-27,Interested In Nymox Pharmaceutical Corporation (NASDAQ:NYMX)? Heres What Its Recent Performance Looks Like
2018-02-05,Nymox Announces US NDA for Fexapotide for BPH
2018-01-30,Fexapotide BPH Phase 3 Clinical Trial Results Published in World Journal of Urology
2018-01-22,Nymox Reports 5-Year Results From Prospective Randomized Controlled Prostate Cancer Study of Fexapotide Triflutate in 146 U.S. Men
2017-12-22,"ETFs with exposure to Nymox Pharmaceutical Corp. : December 22, 2017"
2017-12-11,"ETFs with exposure to Nymox Pharmaceutical Corp. : December 11, 2017"
2017-11-30,"ETFs with exposure to Nymox Pharmaceutical Corp. : November 30, 2017"
2017-11-29,"Nymox Pharmaceutical Corp. :NYMX-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017"
2017-11-27,Nymox Fexapotide Symposium and Panel Discussion at American Urological Association South Central Sectional Annual Meeting in Naples FL
2017-11-16,Nymox Fexapotide Symposium and Panel Discussion at American Urological Association North Central Sectional Annual Meeting in Scottsdale
2017-11-10,Symposium and Panel Discussion on Nymox's Fexapotide To Be Held at American Urological Association North Central Section Annual Meeting in Scottsdale AZ November 15
2017-11-07,"Nymox Reports on Symposium, Panel Discussion and Podium Presentation on Fexapotide at American Urological Association New York Section Annual Meeting in Havana"
2017-10-26,Nymox Pharmaceutical Corporation (NYMX): How Does It Impact Your Portfolio?
2017-10-26,Nymox Announces Two Data Presentations for Company's BPH Drug at New York American Urological Association Meeting November 6
2017-10-13,"Nymox Reports on Symposium, Panel Discussion with Abstract on Fexapotide at American Urological Association Northeast Sectional Annual Meeting in Savannah"
2017-10-10,Nymox Reports on Symposium and Panel Discussion on Fexapotide at American Urological Association Northeast Sectional Annual Meeting in Savannah October 12
2017-09-25,Nymox Announces October 12 Symposium for Company's BPH Drug at American Urological Association Meeting
2017-09-14,Nymox Application Validated:
2017-09-14,Nymox Announces New Symposium for Company's BPH Drug at American Urological Association Meeting October 5
2017-09-12,"ETFs with exposure to Nymox Pharmaceutical Corp. : September 12, 2017"
2017-09-11,AUA Meeting in Florida September 16 Postponed Due to Hurricane
2017-08-31,"ETFs with exposure to Nymox Pharmaceutical Corp. : August 31, 2017"
2017-08-24,"Nymox Pharmaceutical Corp. :NYMX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017"
2017-08-09,Nymox Announces Private Placements of $3 Million
2017-08-07,Nymox Announces Symposium for Company's BPH Drug at American Urological Association Meeting in September
2017-08-03,"ETFs with exposure to Nymox Pharmaceutical Corp. : August 4, 2017"
2017-07-04,"ETFs with exposure to Nymox Pharmaceutical Corp. : July 4, 2017"
2017-05-31,Sexual Function Improves in First-Line Patients Given Fexapotide Treatment in Nymox U.S. BPH Long-Term Clinical Trials
2017-05-24,"Nymox Pharmaceutical Corp. :NYMX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017"
2017-05-16,Nymox reports 1Q loss
2017-05-10,NYMOX Files For Approval of First In Class Prostate Drug in Europe: Teleconference at 4:30 EDT
2017-05-08,NYMOX Files For Approval of First In Class Prostate Drug in Europe: Company To Hold Teleconference Wednesday May 10 at 4:30 EDT
2017-05-03,NYMOX Files For Marketing Approval For Fexapotide Triflutate in Europe
2017-04-05,"Nymox Pharmaceutical Corp. :NYMX-US: Earnings Analysis: Q4, 2016 By the Numbers : April 5, 2017"
2017-04-05,"Nymox Pharmaceutical Corp. :NYMX-US: Earnings Analysis: Q4, 2016 By the Numbers : April 5, 2017"
2017-03-30,Pacific Biosciences of California and Nymox Pharmaceutical Move Up On Bullish Product Environments
2017-03-29,Nymox Provides Update on Fexapotide Development
2016-11-29,Nymox Reports Additional Positive Results From Completed Fexapotide BPH Phase 3 Studies Showing Significant Early Response and First-Line Efficacy
2016-10-12,"Company News for October 12, 2016"
2016-10-12,"Company News for October 12, 2016"
2016-10-11,Nymox Wins Big on Late-Stage Trial
2016-10-11,Nymox Wins Big on Late-Stage Trial
2016-10-11,Nymox Reports Successful New Phase 3 Long-Term Fexapotide Repeat Injection BPH Trial Results: Lasting Symptomatic Improvement Up To 6 Years After Single Repeated Treatment
2016-08-29,Nymox's New Phase 3 Long-Term U.S. Results For Prostate Enlargement Drug Fexapotide Show
2016-08-26,Jabbing a Needle in the Overinflated Nymox Prostate Drug Hype
2016-08-26,Jabbing a Needle in the Overinflated Nymox Prostate Drug Hype
2016-08-25,"Nymox Pharmaceutical Corporation (NYMX) Has More Upside Potential, Even After Gains"
